Skip to main content
CLNN
NASDAQ Life Sciences

Former Board Member Files Intent to Sell $670K in Clene Inc. Shares, Signaling Further Liquidation

Analysis by Wiseek.aiReviewed by Editorial Team
Sentiment info
Negative
Importance info
8
Price
$6.35
Mkt Cap
$74.792M
52W Low
$2.28
52W High
$13.5
Market data snapshot near publication time

summarizeSummary

A former board member of Clene Inc. has filed to sell an additional $670K in shares, continuing a pattern of significant insider distribution amidst the company's going concern warning.


check_boxKey Events

  • Proposed Share Sale

    Symbiosis II LLC, a former board member, intends to sell 104,825 shares of Clene Inc. common stock, with an approximate market value of $669,831.75.

  • Ongoing Insider Distribution

    This proposed sale adds to a pattern of significant insider selling, with Symbiosis II LLC having already sold 280,591 shares for gross proceeds of $1,381,205.63 in the past three months.

  • Context of Financial Uncertainty

    The liquidation by a former insider occurs as Clene Inc. faces substantial doubt about its ability to continue as a going concern, as disclosed in its recent 10-K filing.


auto_awesomeAnalysis

Symbiosis II LLC, a former board member, has filed a Form 144 indicating intent to sell 104,825 shares of Clene Inc. common stock, valued at approximately $669,831.75. This proposed sale represents a significant portion of the company's market capitalization and follows a pattern of substantial sales by this entity, which has already sold over $1.38 million in shares in the past three months. Given the company's recent disclosure of substantial doubt about its ability to continue as a going concern, this continued liquidation by a former insider could be interpreted as a negative signal regarding the company's near-term prospects and financial stability.

At the time of this filing, CLNN was trading at $6.35 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $74.8M. The 52-week trading range was $2.28 to $13.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CLNN - Latest Insights

CLNN
Apr 22, 2026, 5:55 PM EDT
Filing Type: 4
Importance Score:
7
CLNN
Apr 17, 2026, 8:17 PM EDT
Filing Type: 4
Importance Score:
7
CLNN
Apr 15, 2026, 4:05 PM EDT
Filing Type: 144
Importance Score:
8
CLNN
Apr 10, 2026, 4:06 PM EDT
Filing Type: DEFA14A
Importance Score:
8
CLNN
Apr 10, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
CLNN
Mar 31, 2026, 5:05 PM EDT
Filing Type: 144
Importance Score:
7
CLNN
Mar 31, 2026, 4:35 PM EDT
Filing Type: 4
Importance Score:
7
CLNN
Mar 24, 2026, 4:36 PM EDT
Filing Type: 144
Importance Score:
8
CLNN
Mar 17, 2026, 7:00 AM EDT
Filing Type: 10-K
Importance Score:
9
CLNN
Mar 16, 2026, 6:15 PM EDT
Filing Type: 8-K
Importance Score:
8